Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,795,576
-
Total 13F shares
-
30,235,734
-
Share change
-
+783,125
-
Total reported value
-
$510,962,732
-
Put/Call ratio
-
297%
-
Price per share
-
$16.90
-
Number of holders
-
102
-
Value change
-
+$12,287,490
-
Number of buys
-
38
-
Number of sells
-
43
Institutional Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q4 2019
As of 31 Dec 2019 Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) had 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 30,235,734 shares of stock of the company.
Largest 10 holders included ORACLE INVESTMENT MANAGEMENT INC, CREDIT SUISSE AG/, Birchview Capital, LP, BlackRock Inc., AXA, FMR LLC, VANGUARD GROUP INC, Chicago Capital, LLC, ArrowMark Colorado Holdings LLC, and CANNELL PETER B & CO INC.
This table shows 103 institutional shareholders of the security as of 31 Dec 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.